March of Dimes Ohio Collaborative Prematurity Research Center coordinating principal investigator and Cincinnati Children’s Hospital infectious disease pediatrician Dr. Sing Sing Way discusses his team's new findings linking the use of mouthwash in pregnancy with dramatically reduced rates of preeclampsia, preterm birth, and chorioamnionitis.
Dr. Ophelia Yin, an investigator at the March of Dimes Prematurity Research Center at the University of California, San Francisco, on her recent research finding four new genes associated with cellular changes in the uterus during preeclampsia — findings that have helped widen the aperture of preeclampsia research past the placenta and into the uterus.
Dr. Christina Megli, a 2025 March of Dimes Basil O’Connor Starter Scholar Research Award winner, discusses her discovery of 'first responder' macrophage immune cells in the amniotic sac in healthy pregnancy — a finding that may one day lead to new risk prediction tests and therapeutics to slow or prevent preterm birth.
Dr. Brice Gaudillière, an investigator at the March of Dimes Prematurity Research Center at Stanford, on an upcoming Randomized Controlled Trial he is heading that will test two common over the counter drugs — Aspirin and Prevacid, an acid reflux medication — as possible therapeutics to prevent spontaneous preterm birth.
Dr. Frank Lee, a Professor of Pathology and Laboratory Medicine at the University of Pennsylvania Perelman School of Medicine and a 2026 winner of a March of Dimes Discovery Grant, discusses his research on HIF2 gene suppression as a way to treat preeclampsia.